Zepbound a Dual GIP and GLP-1 Receptor Agonist (Dual Agonist) just like Mounjaro, it Mimics two natural incretin hormones. Works centrally to suppress appetite and slow gastric emptying, and peripherally to enhance insulin secretion and reduce glucagon.
- GLP-1 helps to regulate blood sugar levels, which in turn talks to the brain to make you feel less hungry and prevent cravings. It also slows down the emptying of the stomach to keep you feeling fuller for longer.
- GIP regulates energy balance in brain and fat cells, enhancing the GLP-1 effect of suppressing your appetite and improving sugar control.
When Zepbound is used for weight loss, patients loss about 20.9% of their body weight.
Zepbound vs Mounjaro – what is the difference?
Mounjaro is used for type 2 diabetes, and Zepbound is used for weight loss, weight management, and sleep apnea, but they both contain the same active ingredient.
- Generic Name
- tirzepatide
- Dosage form
- single-dose pen (2.5 mg/0.5 mL, 5 mg/0.5 mL, 7.5 mg/0.5 mL, 10 mg/0.5 mL, 12.5 mg/0.5 mL, 15 mg/0.5 mL), single-dose vial (2.5 mg/0.5 mL, 5 mg/0.5 mL)
- Availability
- Prescription only
- Drug Class
- GLP-1 receptor agonists
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Eli Lilly and Company
- National Drug Code (NDC)
- 00002-2506
Reviews
There are no reviews yet.